Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 15;10(1):FSO953.
doi: 10.2144/fsoa-2023-0230. eCollection 2024.

A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs

Fatima Azam  1 , Muhammad Hamza Dawood  2 , Aroosa Roshan  1 , Maryam Urooj  1 , Zoha Khan  1 , Muhammad Omar Larik  1 , Fatima Mustafa Lakdawala  3 , Ahad Yousuf Moulvi  3 , Ifrah Salim  3 , Mehak Abbas Zaidi  3 , Alizeh Imran  3
Affiliations

A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs

Fatima Azam et al. Future Sci OA. .

Abstract

Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the 'top 100 most-cited'. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.

Keywords: antidiabetic drugs; bibliometric analysis; biomedical trends; diabetes; gender bias.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Figures

Figure 1.
Figure 1.
Total citations of articles in the list each year.
Figure 2.
Figure 2.
Number of publications in each 5-year interval.
Figure 3.
Figure 3.
Countries with ten or more articles in the top 100 list.
Figure 4.
Figure 4.
Gender distribution based on first and senior authorship within the top 100 list.
See this image and copyright information in PMC

References

    1. Sampson M, Davies I, Gavrilovic Jet al. . Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type II diabetes. Cardiovasc. Diabetol. 3, 7 (2004). - PMC - PubMed
    1. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of Type II diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88–98 (2018). - PubMed
    1. Schmidt AM. Highlighting diabetes mellitus: the epidemic continues. Arterioscler. Thromb. Vasc. Biol. 38(1), e1–e8 (2018). - PMC - PubMed
    1. Huang K, Zhu J, Xu S, Zhu R, Chen X. Bibliometric and visualized analysis of 2011–2020 publications on physical activity therapy for diabetes. Front. Med. 9, 807411 (2022). - PMC - PubMed
    1. Song Y, Ma P, Gao Y, Xiao P, Xu L, Liu H. A bibliometrics analysis of metformin development from 1980 to 2019. Front. Pharmacol. 12, 645810 (2021). - PMC - PubMed